相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prediction of the crystal structures of axitinib, a polymorphic pharmaceutical molecule
Manolis Vasileiadis et al.
CHEMICAL ENGINEERING SCIENCE (2015)
Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms
Roberta Censi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Influence of pH and method of crystallization on the solid physical form of indomethacin
Alessandra Dubbini et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
Prakash Khadka et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development
Leslie Z. Benet
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Structural, electronic, thermodynamical and charge transfer properties of Chloramphenicol Palmitate using vibrational spectroscopy and DFT calculations
Rashmi Mishra et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2013)
Strategies to Address Low Drug Solubility in Discovery and Development
Hywel D. Williams et al.
PHARMACOLOGICAL REVIEWS (2013)
Characterisation and evaluation of pharmaceutical solvates of Atorvastatin calcium by thermoanalytical and spectroscopic studies
Renu Chadha et al.
CHEMISTRY CENTRAL JOURNAL (2012)
A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept
M. Sherry Ku et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2012)
Enhanced Bioavailability of Atorvastatin Calcium from Stabilized Gastric Resident Formulation
Furquan Nazimuddin Khan et al.
AAPS PHARMSCITECH (2011)
Recent Developments in Crystal Engineering
Kumar Biradha et al.
CRYSTAL GROWTH & DESIGN (2011)
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
N. Jagadeesh Babu et al.
CRYSTAL GROWTH & DESIGN (2011)
Nanonization strategies for poorly water-soluble drugs
Huabing Chen et al.
DRUG DISCOVERY TODAY (2011)
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
Yohei Kawabata et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
QTAIM Application in Drug Development: Prediction of Relative Stability of Drug Polymorphs from Experimental Crystal Structures
Yuriy A. Abramov
JOURNAL OF PHYSICAL CHEMISTRY A (2011)
Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement
Sharad B. Murdande et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2011)
Solid State Characterization of Commercial Crystalline and Amorphous Atorvastatin Calcium Samples
Ganesh Shete et al.
AAPS PHARMSCITECH (2010)
New Crystalline Solvates of Atorvastatin Calcium
Yong Suk Jin et al.
CHEMICAL ENGINEERING & TECHNOLOGY (2010)
High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate
Takashi Kojima et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Development of a Targeted Polymorph Screening Approach for a Complex Polymorphic and Highly Solvating API
Anthony M. Campeta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Crystal engineering: A brief overview
Gautam R. Desiraju
JOURNAL OF CHEMICAL SCIENCES (2010)
Mechanisms for Dehydration of Three Sodium Naproxen Hydrates
Ledjan Malaj et al.
CRYSTAL GROWTH & DESIGN (2009)
Pharmaceutical Cocrystals and Their Physicochemical Properties
Nate Schultheiss et al.
CRYSTAL GROWTH & DESIGN (2009)
The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I
Brian P. Chekal et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2009)
Crystal forms of rifaximin and their effect on pharmaceutical properties
G. C. Viscomi et al.
CRYSTENGCOMM (2008)
Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system
Lei Gao et al.
JOURNAL OF NANOPARTICLE RESEARCH (2008)
Physico-Chemical and Technological Properties of Sodium Naproxen Granules Prepared in a High-Shear Mixer-Granulator
Piera Di Martino et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
N. Blagden et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Salt formation to improve drug solubility
Abu T. M. Serajuddin
ADVANCED DRUG DELIVERY REVIEWS (2007)
Diversity in single- and multiple-component crystals. The search for and prevalence of polymorphs and cocrystals
G. Patrick Stahly
CRYSTAL GROWTH & DESIGN (2007)
A new tetrahydrated form of sodium naproxen
Piera Di Martino et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan
Toshihide Takagi et al.
MOLECULAR PHARMACEUTICS (2006)
Solid state characterization of chloramphenicol palmitate. Raman spectroscopy applied to pharmaceutical polymorphs
MC Gamberini et al.
JOURNAL OF MOLECULAR STRUCTURE (2006)
Rifaximin: A novel nonabsorbed rifamycin for gastrointestinal disorders
JA Adachi et al.
CLINICAL INFECTIOUS DISEASES (2006)
Cyclodextrins in drug delivery: An updated review
R Challa et al.
AAPS PHARMSCITECH (2005)
Rifaximin: In vitro and in vivo antibacterial activity - A review
ZD Jiang et al.
CHEMOTHERAPY (2005)
Impact of solid state properties on developability assessment of drug candidates
LF Huang et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
The computational prediction of pharmaceutical crystal structures and polymorphism
SL Price
ADVANCED DRUG DELIVERY REVIEWS (2004)
General principles of pharmaceutical solid polymorphism:: a supramolecular perspective
B Rodríguez-Spong et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Drug polymorphism and dosage form design: a practical perspective
D Singhal et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Polymorphism in generic drug product development
DA Snider et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Phase transformation considerations during process development and manufacture of solid oral dosage forms
GGZ Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Relationships between crystal structures and thermodynamic properties of phenylbutazone solvates
T Hosokawa et al.
CRYSTENGCOMM (2004)
Crystal structures of drugs: Advances in determination, prediction and engineering
S Datta et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
High-throughput surveys of crystal form diversity of highly polymorphic pharmaceutical compounds
Ö Almarsson et al.
CRYSTAL GROWTH & DESIGN (2003)
Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine
SG Fleischman et al.
CRYSTAL GROWTH & DESIGN (2003)
Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization
SL Morissette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I
AL Grzesiak et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Determination of solubility of polymorphs using differential scanning calorimetry
K Park et al.
CRYSTAL GROWTH & DESIGN (2003)
The use of polymer heteronuclei for crystalline polymorph selection
MD Lang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III
ML Peterson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Form IV of carbamazepine
MD Lang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Physical characterization of naproxen sodium hydrate and anhydrate forms
P Di Martino et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Ritonavir: An extraordinary example of conformational polymorphism
J Bauer et al.
PHARMACEUTICAL RESEARCH (2001)
Crystalline solids
SR Vippagunta et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development
SR Chemburkar et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2000)
Solid-state study of polymorphic drugs: carbamazepine
C Rustichelli et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Improving drug solubility for oral delivery using solid dispersions
C Leuner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
What is the true solubility advantage for amorphous pharmaceuticals?
BC Hancock et al.
PHARMACEUTICAL RESEARCH (2000)
Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate
Y Kobayashi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
分享论文
